Fukoku Mutual Life Insurance’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Buy
+2,411
New +$202K 0.01% 244
2026
Q1
Sell
-2,411
Closed -$206K 240
2025
Q4
$206K Sell
2,411
-256
-10% -$21K 0.01% 237
2025
Q3
$207K Sell
2,667
-445
-14% -$34.8K 0.01% 255
2025
Q2
$243K Sell
3,112
-305
-9% -$22.7K 0.02% 225
2025
Q1
$248K Hold
3,417
0.02% 227
2024
Q4
$253K Hold
3,417
0.02% 226
2024
Q3
$225K Hold
3,417
0.02% 259
2024
Q2
$316K Hold
3,417
0.02% 175
2024
Q1
$327K Sell
3,417
-852
-20% -$71.6K 0.03% 184
2023
Q4
$326K Hold
4,269
0.03% 181
2023
Q3
$296K Hold
4,269
0.03% 189
2023
Q2
$403K Hold
4,269
0.04% 125
2023
Q1
$353K Hold
4,269
0.03% 148
2022
Q4
$319K Hold
4,269
0.03% 193
2022
Q3
$353K Sell
4,269
-540
-11% -$52K 0.03% 159
2022
Q2
$457K Buy
4,809
+2,190
+84% +$227K 0.04% 131
2022
Q1
$308K Buy
+2,619
New +$294K 0.02% 220

Other funds holding EW

Fukoku Mutual Life Insurance's EW Position: Q2 2026 in Review

Fukoku Mutual Life Insurance opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,411 shares worth $218K. The stake represents 0.01% of the portfolio and ranks #244 among its holdings. This is a return to the name: Fukoku Mutual Life Insurance previously reported a position in EW as recently as Q4 2025.

Fukoku Mutual Life Insurance first reported a position in EW in Q1 2022 and has held it in 17 quarters since. The position peaked at $457K in Q2 2022. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Fukoku Mutual Life Insurance held 2,411 shares of Edwards Lifesciences worth $218K as of Q2 2026.
  • Edwards Lifesciences was a new Fukoku Mutual Life Insurance position in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Fukoku Mutual Life Insurance's portfolio in Q2 2026, its #244 holding.
  • Fukoku Mutual Life Insurance first reported a position in Edwards Lifesciences in Q1 2022 and has held it in 17 quarters since.
  • Fukoku Mutual Life Insurance's Edwards Lifesciences position peaked at $457K in Q2 2022.
  • 563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Fukoku Mutual Life Insurance's 13F filing for Q2 2026, filed 24 Jul 2026.